• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.73% Nasdaq Down 0.96%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    49.25 Jul 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:49.25
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:45.96
    Beta:1.04
    Next Earnings Date:10-Aug-15IPXL Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:22.12 - 52.10
    Volume:0
    Avg Vol (3m):769,298
    Market Cap:3.53B
    P/E (ttm):77.56
    EPS (ttm):0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IPXL

    Comparison

    Symbol% ChgMkt Cap
    IPXL 0.00%3.53B
    MYL27.62B
    TEVA61.06B

    Key Statistics

    Forward P/E (1 yr):22.09
    P/S (ttm):5.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.40
    Quarterly EPS Est (Jun-15) :0.35
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):1.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback